Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Innoviva Inc (NASDAQ: INVA)

 
INVA Technical Analysis
4
As on 23rd May 2025 INVA STOCK Price closed @ 18.97 and we RECOMMEND Buy for LONG-TERM with Stoploss of 16.87 & Strong Buy for SHORT-TERM with Stoploss of 15.98 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

INVASTOCK Price

Open 18.74 Change Price %
High 19.10 1 Day 0.15 0.80
Low 18.66 1 Week 0.96 5.33
Close 18.97 1 Month 1.87 10.94
Volume 808174 1 Year 4.53 31.37
52 Week High 20.32 | 52 Week Low 14.40
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
HCTI 0.01 0.00%
NVDA 131.29 -1.16%
EJH 0.10 11.11%
LMDX 0.02 0.00%
PLUG 0.78 -2.50%
AKTS 0.04 0.00%
OPEN 0.68 0.00%
ZJZZT 20.74 1.62%
QUBT 13.31 10.27%
 
NASDAQ USA Top Gainers Stocks
DGLY 2.50 8233.33%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
BCAC 22.71 125.30%
CFFEW 0.11 120.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
SRAX 0.01 -90.00%
PTRAW 0.23 -89.59%
TBIO 0.01 -83.33%
NBSTU 2.00 -82.44%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
 
 
INVA
Daily Charts		 INVA
Intraday Charts		 Whats New @
Bazaartrend		 INVA
Free Analysis
 
INVA Important Levels Intraday
RESISTANCE19.82
RESISTANCE19.55
RESISTANCE19.38
RESISTANCE19.21
SUPPORT18.73
SUPPORT18.56
SUPPORT18.39
SUPPORT18.12
 
INVA Forecast May 2025
Share
4th UP Forecast21.82
3rd UP Forecast20.91
2nd UP Forecast20.34
1st UP Forecast19.78
1st DOWN Forecast18.16
2nd DOWN Forecast17.6
3rd DOWN Forecast17.03
4th DOWN Forecast16.12
 
INVA Weekly Forecast
4th UP Forecast21.28
3rd UP Forecast20.54
2nd UP Forecast20.08
1st UP Forecast19.62
1st DOWN Forecast18.32
2nd DOWN Forecast17.86
3rd DOWN Forecast17.40
4th DOWN Forecast16.66
 
INVA Forecast2025
4th UP Forecast32.52
3rd UP Forecast28.17
2nd UP Forecast25.49
1st UP Forecast22.8
1st DOWN Forecast15.14
2nd DOWN Forecast12.45
3rd DOWN Forecast9.77
4th DOWN Forecast5.42
 
 
INVA Other Details
Segment EQ
Market Capital 1211249024.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
INVA Address
INVA
 
INVA Latest News
 
Your Comments and Response on Innoviva Inc
 
INVA Business Profile
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California. Address: 1350 Old Bayshore Highway, Burlingame, CA, United States, 94010
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service